Paul Volberding

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy

Joel E Gallant, Calvin Cohen, Edwin DeJesus, 2003, AIDS.

Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists?

Winnie Muyindike, Kara Wools-Kaloustian, Constantin Yiannoutsos, 2012, Infectious Agents and Cancer.

What can modeling tell us about the threat of antiviral drug resistance?

Sally Blower, P. Volberding, S. Blower, 2002, Current opinion in infectious diseases.

Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China.

Rosanna Peeling, Barry Bayus, Weiming Tang, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4+ Lymphocytes Are an Incomplete Surrogate Marker for Clinical Progression in Persons with Asymptomatic HIV Infection Taking Zidovudine

Robert Schooley, R. Schooley, S. Lagakos, 1993, Annals of Internal Medicine.

The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine

Mark A. Jacobson, Victor De Gruttola, Martin S. Hirsch, 1995, AIDS.